|
 |
China Pharmaceutical Chain Industry Report, 2007-2008
|
 
Pharmaceutical industry is called as "eternal sunrise industry", mainly because of its sustained growth in market demand. The main factors driving the growth in market demand of China's pharmaceutical industry include economic growth, improved people's awareness of self-health care, the process of aging population and urbanization and full start-up of health system reform, which has greatly promoted the ability and willingness of medical consumption. China's demand for medical industry in the future will maintain a rapid growth. According to the forecasts of IMS, China will become the seventh largest pharmaceutical market in the world in 2009 and will jump to the second largest one with a market capacity of US$220 billion after the U.S.A. in 2020
According to the latest statistics of the National Bureau of Statistics, the sales revenue of China's pharmaceutical industry in the first five months of this year revenue reached CNY271.78 billion, up 26.63% year on year. In 2007, the sales revenue reached CNY575.4 billion, rising 21.5% year on year. The average growth rate of sales revenue of China's pharmaceutical industry in the recent ten years exceeded 20%, far higher than GDP growth rate in the same period. Moreover, the profit growth rate of China's pharmaceutical industry in the past two year was much higher than the growth rate of sales revenue. The total profit of China's pharmaceutical industry in the first eleven months of 2007 reached CNY49.9 billion, jumping 51% year on year. In 2008, the industry continued maintaining the momentum of fast growth, and the total profit of the industry in the first five months of this year stood at CNY26 billion, 41.4% year on year, which is mainly attributed to government support and industry restructuring.
Sales Revenue of China Pharmaceutical Industry, 2001-2008
Source: ResearchInChina
Due to impact of many factors including mainly price competition and market disorder, China's pharmaceutical chain industry was in the doldrums in the past four years in general. However, the industry had a turn for the better in 2007 after experiencing industry restructuring and gradually improved corporate operation in 2006. In 2007, net profit rate of China Top 100 pharmaceutical chain companies reached about 3%, higher than that in the previous year, and the growth rate of profit reached 56.2%, far higher than the growth rate of sales revenue.
Although we are optimistic about our forecast of potential of market development, too fast expansion of pharmaceutical chain industry in large cities like Beijing, Shanghai, Guangzhou and Shenzhen has made market in these large cities tending to be saturated. Rising cost, price competition, new medical reform and other factors have made medium- and small-sized drugstores more and more difficult to survive. It is increasingly clear that China should further restructure its pharmaceutical chain industry to raise industrial concentration degree, which is a very good opportunity for those powerful companies to further strengthen their presence in the industry.
The report is based on the authoritative statistics from the National Bureau of Statistics, the Ministry of Health, the State Food and Drug Administration, the China Association of Pharmaceutical Commerce and China Drugstore website as well as information from annual financial reports and websites of some key companies.
1. Overview of China Pharmaceutical Chain Industry
1.1 Industrial Chain
1.2 China Medical System Reform
1.2.1 Reform Course Review
1.2.2 Basic Framework, Goals and Measures of the New Reform
1.3 Main Factors Driving China Pharmaceutical Industry Development
1.3.1 Economic Growth
1.3.2 Aging Population
1.3.3 Urbanization Process
1.3.4 Push from New Medical System Reform
1.3.5 Improvement in People's Healthcare Awareness
1.3.6 Technology Improvement
1.4 Forecast of Development Trend
2. Operating Status of China Pharmaceutical Industry
2.1 Market Demand
2.1.1 General Size
2.1.2 Main Sub-industries
2.2 Economic Efficiency
2.2.1 Overall Economic Efficiencies
2.2.2 Economic Efficiencies of Main Sub-industries
3. Operating Status of China Pharmaceutical Chain Industry
3.1 Main Industry Indices
3.1.1 Market Size
3.1.2 Profitability
3.1.3 Other Indices
3.2 Consumption Structure
3.3 Price Trend
3.4 Industry Expansion
3.5 Business Mode
4. Competition Status of China Pharmaceutical Chain Industry
4.1 Market Concentration Degree
4.2 Competition Pattern
4.3 Key Enterprises
4.3.1 Comparison of Overall Sizes
4.3.2 Comparison of Economic Efficiencies
5. Key Regions of China Pharmaceutical Chain Industry
5.1 Beijing
5.2 Shanghai
5.3 Guangdong Province
5.4 Jiangsu Province
5.5 Hunan province
5.6 Liaoning Province
5.7 Other Regions
6. Development Trend of China Pharmaceutical Chain Industry
6.1 Market Trend
6.2 Development Trend of Consumption Structure
6.3 Price Trend
6.4 Competition Trend
6.5 Operation Trend
6.5.1 Marketing Era of Drugstore Management
6.5.2 Transformation of Traditional Drugstores
6.5.3 Alliances of Medium- and Small-Sized Drugstores
6.5.4 Return of Directly-Managed Drugstores
6.5.5 Capital Operation：A Major Means of Industry Integration
6.6 Key Concerns
6.6.1 OTC Drugs Market
6.6.2 Medical Care Insurance Medicine
6.6.3 Drug Store Cosmetics
7. Key Companies of China Pharmaceutical Chain Industry
7.1 Laobaixing Drugstore
7.1.1 Company Profile
7.1.2 Revenue Status
7.1.3 Distribution of Chain Stores
7.2 Nepstar Drugstore
7.2.1 Company Profile
7.2.2 Revenue Status
7.2.3 Distribution of Chain Stores
7.3 Hubei Tongjitang Drugstore
7.3.1 Company Profile
7.3.2 Revenue Status
7.3.3 Distribution of Chain Stores
7.4 Chongqing Tongjunge Drugstore
7.4.1 Company Profile
7.4.2 Revenue Status
7.4.3 Distribution of Chain Stores
7.5 Guoda Drugstore of Sinopharm Medicine Holding Co.
7.5.1 Company Profile
7.5.2 Revenue Status
7.5.3 Distribution of Chain Stores
7.6 Liaoning Chengda Fangyuan Chain Drugstore
7.6.1 Company Profile
7.6.2 Revenue Status
7.6.3 Distribution of Chain Stores
7.7 Chongqing Heping Drugstore
7.7.1 Company Profile
7.7.2 Revenue Status
7.7.3 Distribution of Chain Stores
7.8 Jiangxi Kaixinren Drugstore
7.8.1 Company Profile
7.8.2 Revenue Status
7.8.3 Distribution of Chain Stores
7.9 Guangdong Dashenlin Drugstore
7.9.1 Company Profile
7.9.2 Revenue Status
7.9.3 Distribution of Chain Stores
7.10 Yunnan Hongxiang Pharmaceutical Co.(Yixintang Drugstore)
7.10.1 Company Profile
7.10.2 Revenue Status
7.10.3 Distribution of Chain Stores
7.11 Shanghai Huashi Drugstore
7.11.1 Company Profile
7.11.2 Revenue Status
7.11.3 Distribution of Chain Stores
7.12 Hunan Zhilin Drugstore
7.12.1 Company Profile
7.12.2 Revenue Status
7.12.3 Distribution of Chain Stores
7.13 Shenzhen Zhonglian Drugstore
7.13.1 Company Profile
7.13.2 Revenue Status
7.13.3 Distribution of Chain Stores
7.14 Shenyang Northeast Drugstore
7.14.1 Company Profile
7.14.2 Revenue Status
7.14.3 Distribution of Chain Stores
7.15 Beijing Jinxiang Drugstore
7.15.1 Company Profile
7.15.2 Revenue Status
7.15.3 Distribution of Chain Stores
7.16 Tongrentang Drugstore
7.17 Guizhou Yishu Drugstore
7.18 Medicine Shoppe
Industrial Chain of China Pharmaceutical Industry
China Medical System Reform Course
General Framework of Medical System Reform
Sales Revenue of China Pharmaceutical Industry and GDP
China Aging Population Proportion and Changes in Medical Insurance Expenses, 2006-2016
Healthcare Expenditure Per Capita of China Urban & Rural Residents, 2002-2006
China Healthcare Expenditure, 2005-2016
China CPI, Medical Care and Personal Necessity Index Trend
Future Development Trend of China Pharmaceutical Industry
Sales Revenue of China Pharmaceutical Industry, 2001-2008
Growth Rate of China Pharmaceutical Industry and GDP, 2000-2007
Sales Revenue of China Pharmaceutical Industry by Segmented Industry, 2007
Growth Rate of China Pharmaceutical Sub-industries,2003-May 2008
Sales Revenue of Chemical Medicine Sector, 2002-May2008
Sales Revenue of Chemical Medicine Preparation Sector, 2002-May2008
Sales Revenue of Biochemical Medicine Sector, 2002-May2008
Sales Revenue of Chinese Traditional Patent Medicine Sector, 2003-May2008
Sales Revenue of Prepared Herbal Sector, 2003-May2008
Sales Revenue of Health Materials and Medical Supplies Sector, 2002-May2008
Sales Revenue of Animal Medicine Sector, 2002-May2008
Total Profit of China Pharmaceutical Industry, 2002-May2008
Growth Rates of Revenue and Profit of the Industry, 2003-May2008
Changes in Profit Margin of China Pharmaceutical Industry, 2002-May2008
Profit Structure of China Pharmaceutical Industry by Segmented Industry
Profit Growth Rates of China Pharmaceutical Sub-industries,2003-May2008
Profit of Chemical Medicine Sector, 2002-May2008
Profit of Chemical Medicine Preparation Sector, 2002-May2008
Profit of Biochemical Medicine Sector, 2002-May2008
Profit of Chinese Traditional Patent Medicine Sector, 2003-May2008
Profit of Prepared Herbal Sector, 2003-May2008
Profit of Health Materials and Medical Supplies Sector, 2002-May2008
Profit of Animal Medicine Sector, 2002-May2008
Total Sales Revenue of China Top 100 Chain Drugstores, 2003-2007
Profit Margin Distribution of China Top 100 Chain Drugstores, 2007
Daily Average Output Per Square Meter of China Top 100 Chain Drugstores, 2007
Average Index of China Top 100 Chain Drugstores, 2007
Medicine Structure of Medicine Retail Market by Sales in Feb. 2008
China Medicine Retail Price Index, 2003-2007
Total Store Number of China Top 100 Chain Drugstores, 2004-2007
Store Number of China Top 10 Chain Drugstores, 2005-2007
Operating Mode of China Pharmaceutical Chain Industry
Stores Concentration of China Pharmaceutical Chain Industry, 2005-2007
Market Concentration Rate of China Pharmaceutical Chain Industry, 2006-2007
Market Concentration Rate of China Top 100 Chain Drugstores, 2006-2007
Changes in Ranking of China Top 10 Chain Drugstores, 2005-2007
Top 20 Chain Drugstores for Four Years Successively in Terms of Sales
Top 10 Drugstores with the Highest Growth Rate in 2007
Sales List of China Pharmaceutical Chain Industry, 2007(above CNY500 million)
Ranking List of Directly-managed Drugstores Quantity, 2007
Ranking List of Single Store Sales Revenue in the Industry, 2007
Top 10 Companies in Terms of Average Single Store Sales Revenue, 2007
Sales of Main Chain Medicine Companies in Beijing, 2007
Sales of Main Chain Medicine Companies in Shanghai, 2007
Sales of Main Chain Medicine Companies in Guangdong Province, 2007
Sales of Main Chain Medicine Companies in Jiangsu Province, 2007
Local Sales of Main Chain Medicine Companies in Hunan Province, 2007
Sales of Main Chain Medicine Companies in Liaoning Province, 2007
Sales of Main Chain Medicine Companies in Hubei Province, 2007
Sales of Main Chain Medicine Companies in Yunnan Province, 2007
Sales of Main Chain Medicine Companies in Chongqing, 2007
Pharmaceutical Terminal Market Reform
Sales Forecast of China Medicine Retail Market, 2008-2010
Medicine Structure Changes in Retail Market by Sales
Market Share of Homemade Medicine in Retail Market, 2004-2006
Sales List of Cold Medicine in Shanghai Retail Market in Feb. 2008
Changes in Revenue of Laobaixing Drugstore, 2003-2007
Regional Distribution of Laobaixing Drugstores, 2007
Changes in Revenue of Nepstar Drugstore, 2003-2007
Regional Distribution of Nepstar Drugstores, 2005-2007
Changes in Revenue of Hubei Tongjitang Drugstore, 2003-2007
Expansion of Hubei Tongjitang Drugstore, 2003-2007
Changes in Revenue of Chongqing Tongjunge Drugstore, 2003-2007
Expansion of Chongqing Tongjunge Drugstore, 2003-2007
Changes in Revenue of Guoda Drugstore, 2003-2007
Expansion of Guoda Drugstore, 2003-2007
Changes in Revenue of Liaoning Chengda Fangyuan Chain Drugstore, 2003-2007
Expansion of Liaoning Chengda Fangyuan Chain Drugstore, 2003-2007
Changes in Revenue of Chongqing Heping Drugstore, 2003-2007
Expansion of Chongqing Heping Drugstore, 2003-2007
Changes in Revenue of Jiangxi Kaixinren Drugstore, 2003-2007
Expansion of Jiangxi Kaixinren Drugstore, 2003-2007
Changes in Revenue of Guangdong Dashenlin Drugstore, 2003-2007
Expansion of Guangdong Dashenlin Drugstore, 2003-2007
Changes in Revenue of Yixintang Drugstore, 2003-2007
Expansion of Yixintang Drugstore, 2003-2007
Changes in Revenue of Shanghai Huashi Drugstore, 2003-2007
Expansion of Shanghai Huashi Drugstore, 2003-2007
Changes in Revenue of Hunan Zhilin Drugstore, 2003-2007
Expansion of Hunan Zhilin Drugstore, 2003-2007
Changes in Revenue of Shenzhen Zhonglian Drugstore, 2003-2007
Expansion of Shenzhen Zhonglian Drugstore, 2003-2007
Changes in Revenue of Shenyang Northeast Drugstore, 2004-2007
Expansion of Shenyang Northeast Drugstore, 2003-2007
Changes in Revenue of Beijing Jinxiang Drugstore, 2003-2007
Expansion of Beijing Jinxiang Drugstore, 2004-2007
China Pharmaceutical Industry Statistics, 2000-2009 Thanks to the stimulus of new medical system reform launched by the government in 2009, the pharmaceuticals industry of China remains steady growth.
In the first half of 2009, the output of China’s c... China Antibiotic Market Report, 2008-2009 From the perspective of industrial scale, China's output and production capacity of antibiotic raw materials ranks the NO.1 in the world. In 2007, China's sales revenue of antibiotic raw materials rea... China Pharmaceutical Chain Industry Report, 2009 According to the chain drug stores ranking in China in 2009, top 100 enterprises in China pharmaceutical chain industry achieved the sales revenue of RMB57.24 billion in 2008, increasing by RMB13.33 b... China Vaccine Industry Report, 2008-2009 In the past decade, Chinese vaccine market tripled in scale. China has already become the world’s largest vaccine producer and now has 28 vaccine companies, ranking NO.1 around the globe. It can produ... US Pharmaceutical Industry Report, 2008-2009 The United States has the largest pharmaceutical industry in the world. In 2007, its pharmaceutical revenue totaled at US$ 315 billion.
Global Pharmaceutical Output Value and Profits by Region, 2007... Indian Pharmaceutical Formulations Industry Report, 2008-2009 India plays an important role in the global pharmaceutical market. In 2005, 2/5 DMFs to FDA were submitted by India. Currently, there are more than 400 kinds of API (Active Pharmaceutical Ingredient) ... Indian Active Pharmaceutical Ingredients(APIs) Industry Report, 2008-2009 India plays an important part in the global API market. The API output value of India was US $4.1 billion in 2007, with the CAGR as high as 18.81% during 2003-2007. And Indian ranks at the fourth in t... China Chemical Pharmaceutical Market Report, 2008 By the end of Aug, 2008, the total output value of China’s chemical pharmaceutical industry was CNY 273.272 billion, among which, the total output value of active pharmaceutical ingredient (API) was C... China Vaccine Market Report, 2007-2009 China is the largest vaccine producer and consumer in the world. According to the statistics of the General Administration of Customs, China's total vaccine import and export volume reached 34,846 ton... China Pharmaceutical Chain Industry Report, 2007-2008 Pharmaceutical industry is called as "eternal sunrise industry", mainly because of its sustained growth in market demand. The main factors driving the growth in market demand of China's pharmaceutical... China Animal Vaccine Industry Report, 2006-2009 On Jan. 18th of 2008, Ministry of Agriculture of the People's Republic of China and Ministry of Health of China jointly issued the document to intensify the efforts to carry out the inoculation of rab... China Chemical Pharmaceutical Industry Report, 2007 Global medicine industry maintains rapid growth continuously.Its scale has started to maintain fast growth since the middle and late in the 20th century. The total output value increased to USD 602 bi... Company Study of Guangxi Wuzhou Zhongheng Group In 2006, the company received the main business revenue of RMB 321.1685 million, of which the pharmaceutical industry accounted for 62.83%; the profit of main business reached RMB 154.1201 million and... China OTC Drug Market Report, 2007 By 2003, the global OTC drug market had reached 63 billion, and China's OTC drugs shared 5.7% of the global market, only behind North America, West Europe and Japan. In 2003, the sales value in China'... China Pharmaceutical Industry Report, 2006-2007 In Jan-Feb 2007, Product sales revenue of China pharmaceutical industry rose by 17.8% year-on-year and, the gross profits increased by 29.6% from a year earlier.
It is noteworthy that the sales of ch... China Anti-tumor Drugs Market Report, 2007 The anti-tumor drugs market operated well in 2006, and the total sales volume amounted to USD 34.6 billion, up 20.5% from a year earlier, and the growth margin ranked the first place among all the tre... Economic Operation of Pharmaceutical Industry in China, 2006 In 2006, total industrial output value of China pharmaceutical industry accumulated to RMB532.373 billion, up by 17.89% year on year. Total industrial output value of state-owned economy of pharmaceut... China Pharmaceutical Industry Report (Merger and Reorganization), 2006-2007 During the Tenth Five-Year Plan period (2001 to 2005), each indicator of the whole pharmaceutical industry greatly exceeded the scheduled; and the industrial output value, industrial added value and t...
|